We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $12.3M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
-5.68%
1 Year Est. Return
-3.13%
3 Year Est. Return
+108.96%
5 Year Est. Return
-90.91%
10 Year Est. Return
–
AUM
$43.7M
AUM Growth
+$23.6M
Cap. Flow
+$29.6M
Cap. Flow %
67.82%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CBLL
CeriBell Inc
CBLL
+$29.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBLL
1
CeriBell Inc
CBLL
$714M
$28.2M 64.42%
+1,088,101
New +$29.6M
CGON icon
2
CG Oncology
CGON
$6.66B
$14.2M 32.51%
495,526
– –
RPID icon
3
Rapid Micro Biosystems
RPID
$86.2M
$934K 2.14%
1,038,296
– –
LUNG icon
4
Pulmonx
LUNG
$87.6M
$409K 0.94%
60,204
– –

Similar funds

M
MetLife New York $12.3M AUM 29% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
IWM
Immaculate Wealth Management Mesa, Arizona $12.7M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, ABG-WTT Global Life Science Capital Partners held 4 positions worth $43.7M, up 117% from $20.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG-WTT Global Life Science Capital Partners deployed $29.6M of net new capital in Q4 2024, opening 1 new position. Its largest new stake was CeriBell Inc: 1,088,101 shares worth $28.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG-WTT Global Life Science Capital Partners's largest Q4 2024 buy was CeriBell Inc: 1,088,101 shares worth $28.2M.
  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $43.7M portfolio in Q4 2024.
  • ABG-WTT Global Life Science Capital Partners opened 1 new position and closed 0 in Q4 2024.
  • ABG-WTT Global Life Science Capital Partners's portfolio value rose 117% quarter-over-quarter to $43.7M.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.